USFDA conducts inspection at Zydus Lifesciences’ API site in Ahmedabad

23 Dec 2023 Evaluate

United States Food and Drug Administration (USFDA) has conducted an inspection at Zydus Lifesciences’ API site situated at Changodar, Ahmedabad. This PAI-cum-GMP USFDA inspection was conducted from December 14 to December 22, 2023. The inspection closed with 6 observations.

There were no Data Integrity related observations. There are no repeat observations from the previous inspection. There are 4 DMFs of this site under approval with the USFDA. The company will closely work with the USFDA to address the observations. 

Zydus Lifesciences (formerly known as Cadila Healthcare) is an India-based pharmaceutical company. 


Zydus Lifesciences Share Price

931.45 -3.75 (-0.40%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×